A detailed history of Jennison Associates LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 5,632,681 shares of CABA stock, worth $12.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,632,681
Previous 5,546,467 1.55%
Holding current value
$12.7 Million
Previous $41.5 Million 35.92%
% of portfolio
0.02%
Previous 0.03%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$3.94 - $8.24 $339,683 - $710,403
86,214 Added 1.55%
5,632,681 $26.6 Million
Q2 2024

Aug 05, 2024

BUY
$7.22 - $18.82 $15.3 Million - $40 Million
2,123,483 Added 62.04%
5,546,467 $41.5 Million
Q1 2024

May 02, 2024

BUY
$16.79 - $25.38 $30.2 Million - $45.6 Million
1,796,356 Added 110.43%
3,422,984 $58.4 Million
Q4 2023

Feb 01, 2024

BUY
$12.21 - $23.36 $2.49 Million - $4.77 Million
204,261 Added 14.36%
1,626,628 $36.9 Million
Q3 2023

Oct 31, 2023

BUY
$11.84 - $18.65 $2.86 Million - $4.51 Million
241,803 Added 20.48%
1,422,367 $21.6 Million
Q2 2023

Aug 03, 2023

BUY
$7.65 - $13.95 $3.06 Million - $5.58 Million
400,000 Added 51.24%
1,180,564 $15.2 Million
Q1 2023

Apr 26, 2023

BUY
$7.08 - $12.62 $5.53 Million - $9.85 Million
780,564 New
780,564 $6.46 Million

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $65.3M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.